Head, Oncology Department & a Medical Oncologist, Gustave Roussy, France
Member, Scientific Committee, ESMO congress
Guidelines Panel Member, Kidney Cancer, the EAU (European Association of Urology)
Member,  GETUG Steering Committee. 

Professor Laurence Albiges is a medical oncologist and head of the Department of Oncology at Gustave Roussy. 

Her main areas of interest are new therapies for metastatic kidney cancer and rare forms of renal cell carcinoma. She is currently developing translational research programs on these topics. Laurence Albiges is the author of numerous publications in recognized scientific journals. She is associate editor of the journal European Urology Oncology
As a result of her research work, she has received several distinctions, awards and funding, including the Conquer Cancer Foundation Merit Award at the ASCO Genitourinary Symposium in 2015 and the Unicancer-Fondation de France grant. Her research on biomarkers of response to immunotherapy is funded by a K-RTP award.
Her research has been published in peer-reviewed journals that include Journal of Clinical Oncology, The New England Journal of Medicine, Clinical Cancer Research, European Urology, European Journal of Cancer, JAMA Oncology, and Nature Cancer.
Prof. Laurence Albiges is a member of the GETUG steering committee and of the EAU (European Association of Urology) guidelines panel for kidney cancer. She is involved in the ESMO (European Society for Medical Oncology) where she has been a member of the scientific committee of the congress since 2017. She belongs to the cancer committee of the French association of urology. She belongs to the scientific board of the EIKCS (European International Kidney Cancer Symposium) and EMUC (European Multidisciplinary Congress on Urological Cancers). She is a member of the scientific board of the KCA (Kidney Cancer Association).